Greg Madison Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Greg Madison.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Greg Madison. Greg Madison is EVP, Chief Commercial Officer in AMAG PHARMACEUTICALS INC. ($AVM) and President and CEO in KERYX BIOPHARMACEUTICALS INC ($KERX) and President and COO in KERYX BIOPHARMACEUTICALS INC ($KERX).
Latest Insider Trading Transactions of Greg Madison
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22 2018 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Option Exercise | A | 4.16 | 305,000 | 1,268,800 | 305,000 | |
| Mar 22 2018 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Grant | A | 0.00 | 152,500 | 0 | 566,586 | 414.1 K to 566.6 K (+36.83 %) |
| Jan 31 2018 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Grant | A | 4.81 | 4,403 | 21,178 | 429,404 | 433.8 K to 429.4 K (-1.01 %) |
| Jan 31 2018 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Payment of Exercise | F | 5.15 | 58,813 | 302,887 | 433,807 | 492.6 K to 433.8 K (-11.94 %) |
| Jan 31 2018 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Grant | A | 0.00 | 125,000 | 0 | 492,620 | 367.6 K to 492.6 K (+34.00 %) |
| Jan 08 2018 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Sell | S | 4.69 | 1,067 | 5,004 | 367,620 | 368.7 K to 367.6 K (-0.29 %) |
| Oct 31 2017 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Sell | S | 6.03 | 4,055 | 24,452 | 368,687 | 372.7 K to 368.7 K (-1.09 %) |
| Oct 06 2017 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Sell | S | 7.19 | 895 | 6,435 | 372,742 | 373.6 K to 372.7 K (-0.24 %) |
| Aug 01 2017 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Sell | S | 7.14 | 4,131 | 29,495 | 373,637 | 377.8 K to 373.6 K (-1.09 %) |
| Jul 06 2017 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Sell | S | 7.67 | 910 | 6,980 | 377,768 | 378.7 K to 377.8 K (-0.24 %) |
| Apr 06 2017 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Sell | S | 5.80 | 911 | 5,284 | 382,800 | 383.7 K to 382.8 K (-0.24 %) |
| Mar 15 2017 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Option Exercise | A | 5.53 | 300,000 | 1,659,000 | 300,000 | |
| Mar 15 2017 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Grant | A | 0.00 | 150,000 | 0 | 383,711 | 233.7 K to 383.7 K (+64.18 %) |
| Feb 13 2017 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Sell | S | 5.47 | 1,611 | 8,812 | 233,711 | 235.3 K to 233.7 K (-0.68 %) |
| Jan 31 2017 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Sell | S | 4.65 | 18,248 | 84,853 | 235,322 | 253.6 K to 235.3 K (-7.20 %) |
| Jan 06 2017 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Sell | S | 6.16 | 1,077 | 6,634 | 253,570 | 254.6 K to 253.6 K (-0.42 %) |
| Nov 14 2016 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Sell | S | 4.99 | 1,559 | 7,779 | 254,647 | 256.2 K to 254.6 K (-0.61 %) |
| Oct 06 2016 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Sell | S | 5.38 | 917 | 4,933 | 256,206 | 257.1 K to 256.2 K (-0.36 %) |
| Aug 11 2016 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Sell | S | 4.22 | 1,622 | 6,845 | 257,123 | 258.7 K to 257.1 K (-0.63 %) |
| Aug 11 2016 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Sell | S | 4.22 | 1,622 | 6,845 | 257,123 | 258.7 K to 257.1 K (-0.63 %) |
| Jul 06 2016 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Sell | S | 6.66 | 936 | 6,234 | 258,745 | 259.7 K to 258.7 K (-0.36 %) |
| May 10 2016 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Sell | S | 5.42 | 1,873 | 10,152 | 259,681 | 261.6 K to 259.7 K (-0.72 %) |
| Apr 07 2016 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Sell | S | 4.50 | 1,078 | 4,851 | 261,554 | 262.6 K to 261.6 K (-0.41 %) |
| Feb 10 2016 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Sell | S | 3.23 | 1,938 | 6,260 | 262,632 | 264.6 K to 262.6 K (-0.73 %) |
| Feb 01 2016 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Option Exercise | A | 3.35 | 307,500 | 1,030,125 | 307,500 | |
| Feb 01 2016 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Grant | A | 0.00 | 153,750 | 0 | 264,570 | 110.8 K to 264.6 K (+138.74 %) |
| Jan 06 2016 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Sell | S | 4.83 | 4,261 | 20,581 | 110,820 | 115.1 K to 110.8 K (-3.70 %) |
| Nov 12 2015 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Sell | S | 5.18 | 1,638 | 8,485 | 115,081 | 116.7 K to 115.1 K (-1.40 %) |
| Aug 24 2015 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Buy | P | 5.69 | 9,984 | 56,759 | 116,719 | 106.7 K to 116.7 K (+9.35 %) |
| Aug 12 2015 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Sell | S | 6.07 | 1,683 | 10,216 | 106,735 | 108.4 K to 106.7 K (-1.55 %) |
| May 12 2015 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and CEO | Payment of Exercise | F | 9.32 | 1,625 | 15,145 | 108,418 | 110 K to 108.4 K (-1.48 %) |
| Mar 10 2015 | KERX | KERYX BIOPHARMACEU ... | Madison Greg | President and COO | Sell | P | 12.53 | 6,380 | 79,941 | 110,043 | 116.4 K to 110 K (-5.48 %) |
| Mar 04 2013 | AVM | AMAG PHARMACEUTICA ... | Madison Greg | EVP, Chief Commerci ... | Option Exercise | A | 16.55 | 37,500 | 620,625 | 37,500 | |
| Mar 04 2013 | AVM | AMAG PHARMACEUTICA ... | Madison Greg | EVP, Chief Commerci ... | Grant | A | 0.00 | 12,500 | 0 | 18,800 | 6.3 K to 18.8 K (+198.41 %) |
| Mar 04 2013 | AVM | AMAG PHARMACEUTICA ... | Madison Greg | EVP, Chief Commerci ... | Grant | A | 0.00 | 6,300 | 0 | 6,300 | 0 to 6.3 K |
Page: 1